Conceptus (NSDQ:CPTS) agreed to a buyout by Bayer (PINK:BAYRY) in a deal valued at $1.1 billion.
Conceptus Inc.
Mayo Clinic diabetes initiative nabs former Medtronic exec | Personnel Moves
Conceptus hits 52-week high on swing to Q4, 2012 black
Conceptus is back in the black in Q3
Conceptus (NSDQ:CPTS) touted a Q3 return to the black, back from previous losses reporting for the same period last year.
The Mountain View medical device maker posted $2.3 million net income, or 7¢ per share, on sales of $35.5 million. That compared with net loss of $2.9 million, or 9¢ per share, during the same period last year.
Medical device moves: Marketing veep Trujillo out at Conceptus
Conceptus hires former Edwards sales, marketing rep | Personnel Moves
Hologic falls on swing to Q2 red, Gen-Probe deal
Incoming BSX CEO Mahoney’s 2011 total tops $11.5M | Personnel Moves
FDA nod for Hologic’s NovaSure buoys rival Conceptus | Regulatory Roundup
FDA nod for Hologic’s NovaSure buoys rival Conceptus
Is Boston Scientific in line for a private equity takeover? | Wall Street Beat
Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.
